These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12459112)

  • 41. A case report of pregnancy in renal transplant recipient treated with FK506 (tacrolimus).
    Yoshimura N; Oka T; Fujiwara Y; Ohmori Y; Yasumura T; Honjo H
    Transplantation; 1996 May; 61(10):1552-3. PubMed ID: 8633388
    [No Abstract]   [Full Text] [Related]  

  • 42. Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.
    Hardy G; Stanke-Labesque F; Contamin C; Serre-Debeauvais F; Bayle F; Zaoui P; Bessard G
    Eur J Clin Pharmacol; 2004 Oct; 60(8):603-5. PubMed ID: 15378223
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute right heart failure caused by tacrolimus after renal transplantation: Serial observation by speckle tracking and Doppler echocardiography.
    Igata S; Wettersten N; Wong DJ; Sabet A; DeMaria AN
    Echocardiography; 2017 Nov; 34(11):1730-1732. PubMed ID: 29178293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports.
    Scheel AK; Blaschke S; Schettler V; Mayer C; Müller GA; Bittermann HJ; Grunewald RW
    Transplant Proc; 2001; 33(7-8):3693-4. PubMed ID: 11750573
    [No Abstract]   [Full Text] [Related]  

  • 45. Tacrolimus associated to posterior reversible atypical encephalopathy syndrome and brain haemorrhage in renal transplant recipient.
    Cadavid-Aljure D; Caicedo-Paredes A; Meza JC; Granados-Sánchez AM; Posada-Chávez JG; Mesa-Ramírez L; Schweineberg-López J
    Nefrologia; 2012; 32(6):861-3. PubMed ID: 23169384
    [No Abstract]   [Full Text] [Related]  

  • 46. Tacrolimus (FK 506) in kidney transplantation.
    Vanrenterghem Y
    Transplant Proc; 1998 Aug; 30(5):2171-3. PubMed ID: 9723431
    [No Abstract]   [Full Text] [Related]  

  • 47. Tacrolimus Toxicity With Minimal Clinical Manifestations: A Case Report and Literature Review.
    Haroon N; Singh A; Bhat ZY
    Am J Ther; 2016; 23(2):e631-4. PubMed ID: 25730156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case showing complete insulin independence after severe diabetic ketoacidosis associated with tacrolimus treatment.
    Cho YM; Park KS; Jung HS; Kim YS; Kim SY; Lee HK
    Diabetes Care; 2002 Sep; 25(9):1664. PubMed ID: 12196452
    [No Abstract]   [Full Text] [Related]  

  • 49. Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus.
    Pirmez R; Price VH; Cuzzi T; Trope BM
    Australas J Dermatol; 2016 May; 57(2):156-7. PubMed ID: 27124649
    [No Abstract]   [Full Text] [Related]  

  • 50. Pneumocystis carinii pneumonia after renal transplantation.
    van Hooff JP
    Transplantation; 1997 May; 63(9):1370. PubMed ID: 9158038
    [No Abstract]   [Full Text] [Related]  

  • 51. Fever of unknown origin in renal transplant patients with tacrolimus.
    Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
    Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant.
    Ogunseinde BA; Wimmers E; Washington B; Iyob M; Cropper T; Callender CO
    Transplantation; 2003 Jul; 76(2):448. PubMed ID: 12883222
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interaction between tacrolimus and theophylline in a renal transplant recipient: a case report].
    Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A
    Therapie; 2011; 66(6):553-4. PubMed ID: 22186080
    [No Abstract]   [Full Text] [Related]  

  • 55. Bilateral femoral capital avascular necrosis in a renal transplant recipient on tacrolimus-based immunosuppression.
    Nayagam LS; Rajan SG; Khandelwal N; Sen R; Kohli HS; Sud K; Gupta KL; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2005 Oct; 20(10):2262-4. PubMed ID: 16030048
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical management of tacrolimus drug interactions in renal transplant patients.
    Moreno M; Latorre A; Manzanares C; Morales E; Herrero JC; Dominguez-Gil B; Carreño A; Cubas A; Delgado M; Andres A; Morales JM
    Transplant Proc; 1999 Sep; 31(6):2252-3. PubMed ID: 10500564
    [No Abstract]   [Full Text] [Related]  

  • 57. Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation.
    Lauzurica R; Loscos J; Diaz-Couchod P; Bayés B; de la Camara J
    Transplantation; 2002 Mar; 73(6):1006-7. PubMed ID: 11923710
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 59. Sublingual administration of tacrolimus in a renal transplant patient.
    Romero I; Jiménez C; Gil F; Escuin F; Ramirez E; Fudio S; Borobia A; Carcas A
    J Clin Pharm Ther; 2008 Feb; 33(1):87-9. PubMed ID: 18211623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Irreversible Lesions of Tacrolimus-induced Posterior Reversible Leukoencephalopathy Syndrome.
    Savaj S; Farasatinasab M; Amouzegar A
    Iran J Kidney Dis; 2017 Nov; 11(6):408. PubMed ID: 29190599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.